药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Heptabarbital
Abexinostat
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Abexinostat.
Heptabarbital
Mizolastine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Mizolastine.
Heptabarbital
Ricolinostat
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Ricolinostat.
Heptabarbital
Simendan
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Simendan.
Heptabarbital
CUDC-101
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with CUDC-101.
Heptabarbital
Entinostat
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Entinostat.
Heptabarbital
Mocetinostat
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Mocetinostat.
Heptabarbital
Amifampridine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Amifampridine.
Heptabarbital
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Dexchlorpheniramine maleate.
Heptabarbital
Benidipine
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Benidipine.
Heptabarbital
Melperone
The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Melperone.
Heptabarbital
Butriptyline
The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Lenvatinib.
Heptabarbital
Eperisone
The risk or severity of QTc prolongation can be increased when Eperisone is combined with Lenvatinib.
Heptabarbital
Fendiline
The risk or severity of QTc prolongation can be increased when Fendiline is combined with Lenvatinib.
Heptabarbital
Bedaquiline
The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Lenvatinib.
Heptabarbital
Antazoline
The risk or severity of QTc prolongation can be increased when Antazoline is combined with Lenvatinib.
Heptabarbital
Nilvadipine
The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Lenvatinib.
Heptabarbital
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Lenvatinib.
Heptabarbital
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Lenvatinib.
Heptabarbital
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Lenvatinib.